Importance of the RNA Binding Protein Hu-antigen R in malignant Melanoma (2018) Liebig J, Boßerhoff AK Conference contribution Extracellular Acidosis leads to the Development of a senescent-like Phenotype and molecular Reprogramming of human Melanoma Cells (2018) Böhme I, Boßerhoff AK Conference contribution CYLD - A potential Mediator of tissue-specific Melanoma Metastasis (2018) Schott M, de Jel MM, Boßerhoff AK, Kuphal S Conference contribution SiRNA-Knockdown einer neuen Argonaute2 Spleißvariante verringert die tumorigenen Eigenschaften von Melanomzellen. (2018) Linck L, Boßerhoff AK Conference contribution, Abstract of a poster Positionspapier: Telemedizin in der Berufsdermatologie - Aktueller Stand und Perspektiven (2018) Elsner P, Bauer A, Diepgen TL, Drexler H, Fartasch M, John SM, Schliemann S, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Anti-PD-1 Therapy in SUFU mutant Patients with Gorlin-Goltz Syndrome (2018) Moreira A, Kirchberger MC, Toussaint F, Erdmann M, Schuler G, Heinzerling L Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution Tumor-suppressing Plasma extracellular Vesicles (pEV) from Melanoma Patients are secreted by Liver Cells and PBMC (2018) Baur A, Lee JH, Eberhardt M, Blume K, Schuler G, Vera González J Conference contribution The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Marz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution